Tuesday May 7
ZIOPHARM Announces First Quarter Financial Results and Key Developments
ZIOPHARM Oncology, Inc. today announced financial results for the first quarter ended March 31, 2013, and provided an update on the Company's key developments.
Do Hedge Funds and Insiders Love ZIOPHARM Oncology Inc. (ZIOP)?
ZIOPHARM Oncology Inc. was in 6 hedge funds' portfolio at the end of December. ZIOP investors should pay attention to a decrease in activity from the world's largest hedge funds in recent months.
ZIOPHARM Oncology, Inc. Presents Preclinical Data Supporting...
ZIOPHARM Oncology, Inc. , a biopharmaceutical company focused on the development and commercialization of new cancer therapies, announced today the presentation of results from a study in a breast cancer murine model demonstrating the anti-tumor effects and tolerability of Ad-RTS-mIL-12, a viral vector DNA-based therapeutic for the controlled, ... (more)